Skip to content

Clinical trials

Observational Carcinoma, Ovarian Epithelial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Phase: Observational Clear all

93 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20022
20032
20042
20054
20064
20077
20085
20094
20104
20122
20131
20151
20161
20175
20182
20197
20207
20214
20224
20237
20244
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Unknown status24
Recruiting12
Terminated12
Withdrawn5
Not yet recruiting4
Active, not recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Lei Li10
Vanderbilt-Ingram Cancer Center5
Asan Medical Center3
RenJi Hospital3
ARCAGY/ GINECO GROUP2
European Organisation for Research and Treatment of Cancer - EORTC2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS2
Grupo Español de Investigación en Cáncer de Ovario2
Gynecologic Oncology Group2
M.D. Anderson Cancer Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial93
Ovarian Neoplasms42
Fallopian Tube Neoplasms20
Breast Neoplasms15
Carcinoma, Non-Small-Cell Lung12
Colonic Neoplasms9
Endometrial Neoplasms8
Burkitt Lymphoma7
Colorectal Neoplasms7
Leukemia, Lymphocytic, Chronic, B-Cell7

Trials

Showing 26 to 50 of 93. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.